These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 33071079)

  • 41. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
    Abutaleb NS; Seleem MN
    Sci Rep; 2020 May; 10(1):7701. PubMed ID: 32382070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
    Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
    J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological Management of Pediatric Clostridioides difficile Infection: Clarifying the Controversies.
    DeVine MN; MacBrayne CE; Child J; Blackmer AB
    J Pediatr Health Care; 2022; 36(2):181-192. PubMed ID: 34412953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and therapy of severe Clostridioides difficile infections in the ICU.
    Guery B; Barbut F; Tschudin-Sutter S
    Curr Opin Crit Care; 2020 Oct; 26(5):450-458. PubMed ID: 32739967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
    Sattler MM; Crews JD
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S27-S33. PubMed ID: 34791399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection.
    Cheng AC; Ferguson JK; Richards MJ; Robson JM; Gilbert GL; McGregor A; Roberts S; Korman TM; Riley TV;
    Med J Aust; 2011 Apr; 194(7):353-8. PubMed ID: 21470086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Connecticut medical providers' concordance with 2017 IDSA/SHEA
    Luc CM; Olson D; Banach DB; Clogher P; Hadler J
    Infect Control Hosp Epidemiol; 2021 May; 42(5):549-556. PubMed ID: 33234174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can Emergency Department Wait Times Predict Rates of Hospital-Acquired Clostridioides difficile Infection? A Study of Acute Care Facilities in New York State.
    Durant DJ; Young CG
    J Patient Saf; 2022 Mar; 18(2):e508-e513. PubMed ID: 34009865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
    Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
    Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent Clostridium difficile infection: what are the treatment options?
    van Nispen tot Pannerden CM; Verbon A; Kuipers EJ
    Drugs; 2011 May; 71(7):853-68. PubMed ID: 21568363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
    Hawes AM; Desai A; Patel PK
    Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of clinical decision support for outpatient management of
    Wu T; Davis SL; Church B; Alangaden GJ; Kenney RM
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1345-1348. PubMed ID: 34583800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection.
    Misawa K; Iketani O; Enoki Y; Taguchi K; Uno S; Uwamino Y; Hasegawa N; Matsumoto K
    J Infect Chemother; 2021 Oct; 27(10):1407-1412. PubMed ID: 34023223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical review of Clostridium difficile infection: an update on treatment and prevention.
    Daniels LM; Kufel WD
    Expert Opin Pharmacother; 2018 Nov; 19(16):1759-1769. PubMed ID: 30220230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan.
    Wu KS; Syue LS; Cheng A; Yen TY; Chen HM; Chiu YH; Hsu YL; Chiu CH; Su TY; Tsai WL; Chen WY; Huang CH; Hung HM; Huang LJ; Kuo HJ; Lin PC; Yang CH; Hong PL; Lee SS; Chen YS; Liu YC; Huang LM; ; ; ; ;
    J Microbiol Immunol Infect; 2020 Apr; 53(2):191-208. PubMed ID: 32169531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
    Igarashi Y; Tashiro S; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
    J Infect Chemother; 2018 Nov; 24(11):907-914. PubMed ID: 30170735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How can patients with Clostridioides difficile infection on concomitant antibiotic treatment be best managed?
    Fitzpatrick F; Safdar N; van Prehn J; Tschudin-Sutter S
    Lancet Infect Dis; 2022 Nov; 22(11):e336-e340. PubMed ID: 35617982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.